https://techcrunch.com/2022/03/31/novaxs-biotech-raises-1-5m-to-make-injection-therapy-needle-free/

A startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which it hopes can make therapies that traditionally require daily self-administered medicines less painful.

NovaXS Biotech, founded by 21-year-old Berkeley researcher Alina Su in 2020, recently closed a $1.5 million seed round led by Lei Ming, an angel investor known for co-founding Chinese search giant Baidu in 1999. Other investors included Chinese venture capital firms Taihill Venture and NewGen VC as well as American ones: Courtyard Ventures, a fund focused on UC Berkeley startups, MHub Impact Fund, an innovation hub based out of Chicago, medical device maker Baxter, and Edward Elmhurst Health, an integrated health system in Illinois.